Fish Oil May Help Prevent Psychosis, Schizophrenia
the Psychiatry Advisor take:
Omega-3 fatty acid supplements may be effective in reducing the long-term risk of developing psychosis.
Paul Amminger, MD, PhD, of the University of Melbourne, Australia, and colleagues enrolled 81 people between the ages of 13 and 25 years old who were said to be at risk of developing psychosis and schizophrenia. Forty-one were given fish oil supplements for three months, while the rest were given a placebo.
After the three months, the participants were followed for another 12 months. During that time, only two of the 41 patients on fish oil developed a psychotic disorder, the researchers reported in the journal Nature Communications. But in the placebo group, 11 participants reported such a disorder.
Even more remarkable, seven years after the original study was completed, only 10% — four of the 41 — had developed a psychotic disorder. Meanwhile, in the placebo group, the figure was 16.
Fish oil “may offer a viable longer-term prevention strategy with minimal associated risk in young people at ultra-high risk of psychosis.”
Benefits of omega-3 fatty acids in averting psychosis seen for years after fish oil supplements stopped being taken.
In what is to be believed the first study of its kind, new research has revealed the omega-3 fatty acids found in fish oil may be effective for reducing the risk of psychosis.
The study was published in Nature Communications and details how a 12-week intervention with omega-3 supplements substantially reduced the long-term risk of developing psychotic disorders.
The use of fish oil has long been in the public eye and has been heralded by some as an essential component of our physical well-being, but can it also improve our mental health?
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Etiology of Schizophrenia: Strong Association With Certain Rare Copy Number Variants
- Long-Term Lithium Use: More Evidence Needed to Associate With Cancer Risk
- FDA to Review Lumateperone for Treatment of Schizophrenia
- Evzio Authorized Generic Soon to Be Available
- AMA Survey Collects Advice for Physicians Approaching Retirement
- Cannabis Use, Cannabis Use Disorder Linked to Psychotic, Depressive Symptoms
- Abstinence From Regular Cannabis Use Improves Memory Among Adolescents, Young Adults
- Group Cognitive Behavioral Therapy Is Effective Treatment for Adolescent Anxiety
- Association Between Opioid and Benzodiazepine Misuse and Suicidal Ideation
- The Intersection of Eating and Alcohol Disorders: Detecting and Managing "Drunkorexia"
- Cognition, Depression, and Limited Functioning Linked in Middle Age
- Coping With Challenges When Working the Holidays
- Lithium Preferred Method of Maintenance Monotherapy in Older Adults With Bipolar Disorder
- Hypobetalipoproteinemia Associated With Aggression and Schizophrenia
- AMA Code of Medical Ethics Guides Physicians in Fighting Harmful Online Health Information